Earnings Call · Q1 FY2026·2026-05-06

Q1 26EPS -66.67%·Rev n/aQ4 25EPS +25.45%·Rev n/aQ3 25EPS +100.00%*·Rev n/aQ2 25EPS +100.00%*·Rev n/a⚠ consensus missing

Niagen Bioscience, Inc. NAGE

Lauren Rittman-Borzansky — Investor Relations

Rob Fried — Chief Executive Officer

Ozan Pamir — Chief Financial Officer

+3.1%1d on move date+1.7% vs SPY3d−13.5%5d−20.1%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more NAGE calls or request research access.

More NAGE calls Browse calls Request research access